These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9019118)

  • 41. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1997 Jul; 278(1):15. PubMed ID: 9207323
    [No Abstract]   [Full Text] [Related]  

  • 42. The use and abuse of psychostimulants.
    Gock SB; Skrinska VA
    Clin Lab Sci; 2005; 18(2):114-8. PubMed ID: 15916244
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fatal poisoning with Letigen].
    Kanstrup MH; Petersen AP
    Ugeskr Laeger; 2003 Jan; 165(3):239-40. PubMed ID: 12555708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response to comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
    El-Zein RA; Hay MJ; Lopez MS; Bondy ML; Morris DL; Legator MS; Abdel-Rahman SZ
    Cancer Lett; 2006 Jan; 231(1):146-8. PubMed ID: 16290920
    [No Abstract]   [Full Text] [Related]  

  • 45. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood.
    Dees RH
    Neurology; 2005 Apr; 64(7):1320; author reply 1320. PubMed ID: 15832458
    [No Abstract]   [Full Text] [Related]  

  • 46. [The addiction of ephedrine like psychostimulators and use of nimotop for its correction].
    Voloshina NP; Levchenko IL; Volganova IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):51-5. PubMed ID: 15849865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ephedrine-induced cardiopathy.
    Van Mieghem W; Stevens E; Cosemans J
    Br Med J; 1978 Apr; 1(6116):816. PubMed ID: 638463
    [No Abstract]   [Full Text] [Related]  

  • 48. Urinary retention associated with ephedrine.
    Glidden RS; DiBona FJ
    J Pediatr; 1977 Jun; 90(6):1013-4. PubMed ID: 859049
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of narcolepsy with nialamide and ephedrine].
    Baumgarten HG
    Klin Wochenschr; 1968 Mar; 46(6):334-5. PubMed ID: 5682016
    [No Abstract]   [Full Text] [Related]  

  • 50. [Analeptic amines in the therapy of obesity].
    JORES A; LOOS M; SPIEGELBERG U
    Medizinische; 1952 Jun; 31(24):815-8. PubMed ID: 12982388
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of controlled-substance monitoring of ephedrine use and medication waste.
    Seman M; Craner RC; Buckner Petty SA; Kraus MB
    J Clin Anesth; 2021 Dec; 75():110449. PubMed ID: 34333449
    [No Abstract]   [Full Text] [Related]  

  • 52. Coronary thrombosis related to use of Xenadrine RFA.
    Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
    Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ephedrine abuse among 36 female weightlifters.
    Gruber AJ; Pope HG
    Am J Addict; 1998; 7(4):256-61. PubMed ID: 9809129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dangerously revved. Ephedrine misuse poses health hazards.
    Jones TL
    Tex Med; 1996 May; 92(5):52-3. PubMed ID: 8775849
    [No Abstract]   [Full Text] [Related]  

  • 55. "All but death, can be adjusted". Ma Huang (ephedrine) adversities.
    Mack RB
    N C Med J; 1997; 58(1):68-70. PubMed ID: 9019118
    [No Abstract]   [Full Text] [Related]  

  • 56. Ephedra in perspective--a current review.
    Abourashed EA; El-Alfy AT; Khan IA; Walker L
    Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myths and facts...about ephedrine use.
    Munson BL
    Nursing; 2003 Apr; 33(4):81. PubMed ID: 12722724
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.